Alpha Tau Medical
Dr. Domankevich is an experienced cancer researcher since 2004. She holds a M.Sc degree from the Tel Aviv University and a Ph.D degree from the University of Haifa, where she studied psycho-neuro-immunology aspects of experimental breast metastases and the mechanisms underlying genomic integrity of cancer resistant mammals. Dr. Domankevich is responsible for the company’s translational research, focusing on combinational treatments with immunotherapy. Dr. Domankevich holds a BSc in Information Systems Engineering from the Technion and had worked in software engineering for eight years.
This person is not in any offices
Alpha Tau Medical
Alpha Tau Medical (https://www.alphatau.com/) focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-Emitters Radiation Therapy) for the treatment of solid cancer tumors. Initially developed at Tel Aviv University, Alpha DaRT was shown to be effective and safe for treating different types of cancer in multiple animal studies. The company is running its first clinical trial in several sites in the EU and is currently commencing clinical trials at over 55 leading cancer centers worldwide.